GYRE THERAPEUTICS, INC.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value $10.3m $14.5m $31.2m $15.4m $30.4m $44.3m $21.7m $33.5m $11.8m $37.1m
Prepaid Expense and Other Assets, Current $958k $1.3m $3.8m $4.2m $6.8m $2.8m $1.5m
Cash, Cash Equivalents, and Short-term Investments $17.1m $32.4m $120.1m $76.9m $81.9m $46.9m $21.7m $33.5m
Short-term Investments $6.8m $18.0m $88.9m $61.5m $49.0m $2.5m $14.9m $15.4m
Inventory, Net $4.3m $6.3m $10.2m
Assets, Current $37.5m $39.1m $124.0m $96.1m $89.5m $51.5m $28.2m $57.2m $64.8m $102.4m
Property, Plant and Equipment, Net $444k $276k $386k $304k $433k $970k $4k $23.3m $23.9m $23.6m
Operating Lease, Right-of-Use Asset $1.9m $1.8m $2.7m $66k $489k $1.8m $1.1m
Other Assets, Noncurrent $128k $543k $257k $528k $472k $168k $995k $3.0m $2.5m
Additional Financial Items
Accounts Receivable, after Allowance for Credit Loss, Current $15.0m $3.3m $1.8m $19.6m $31.1m
Assets $38.1m $39.5m $124.9m $98.6m $94.8m $55.7m $28.4m $116.5m $125.4m $166.1m
LIABILITIES AND EQUITY
Current liabilities:
Operating Lease, Liability, Current $483k $663k $2.0m $38k $210k $713k $636k
Accounts Payable, Current $837k $747k $1.2m $4.3m $5.9m $6.4m $194k $355k $108k $124k
Operating Lease, Liability, Noncurrent $1.3m $981k $408k $121k $199k $885k $303k
Deferred Revenue, Current $283k $212k $15.0m $2.0m $230k $145k $39k
Deferred Revenue, Noncurrent $47k $212k $15.0m $2.0m $230k $145k $213k $928k $852k
Dividends Payable, Current $8
Liabilities, Current $22.0m $8.7m $4.8m $28.9m $17.8m $14.2m $16.8m $20.0m $19.5m $18.3m
Other Liabilities, Noncurrent $49k $7k $1.4m
Deferred Tax Liabilities, Net $2.5m $8.3m $9.6m
Liabilities $22.0m $8.7m $5.0m $30.2m $18.8m $14.6m $16.8m $38.1m $27.0m $23.9m
Stockholders’ equity:
Common Stock, Value, Issued $1k $6k $12k $12k $22k $31k $37k $77k $86k $91k
Additional Paid in Capital $164.1m $204.3m $323.3m $326.8m $390.8m $443.8m $389.2m $68.2m $136.2m $172.0m
Retained Earnings (Accumulated Deficit) ($148.0m) ($173.5m) ($203.3m) ($258.5m) ($314.8m) ($402.7m) ($410.9m) ($85.5m) ($73.5m) ($68.4m)
Accumulated Other Comprehensive Income (Loss), Net of Tax ($1k) ($4k) $34k $5k ($392k) ($1.6m) ($2.6m) ($779k)
Stockholders' Equity Attributable to Parent $16.1m $30.8m $119.9m $68.3m $76.1m $41.1m ($21.7m) ($15.8m) $63.3m $106.0m
Stockholders' Equity Attributable to Noncontrolling Interest $29.8m $35.1m $36.3m
Liabilities and Equity $38.1m $39.5m $124.9m $98.6m $94.8m $55.7m $28.4m $116.5m $125.4m $166.1m